显微手术与放疗后前庭神经鞘瘤的长期听力结局:系统综述与Meta分析
该系统综述与Meta分析检索Scopus、Pubmed和Web of Science至2024年1月,纳入9项研究共356例患者,评估前庭神经鞘瘤积极治疗后长期可服务听力。立体定向放射外科治疗10年维持可服务听力的合并患病率为18.1%(95%CI:1.7%-43.3%),显微手术为74.5%(95%CI:63.5%-84.1%)。
要点
- 立体定向放射外科治疗10年维持可服务听力的合并患病率为18.1%(95%CI:1.7%-43.3%)。
- 显微手术维持长期可服务听力的合并估计值为74.5%(95%CI:63.5%-84.1%)。
- 长期随访对评估前庭神经鞘瘤治疗后的听力结局具有重要意义。
核心结论
- 本系统综述强调长期随访在评估前庭神经鞘瘤治疗听力结局中的重要性。
- 尽管存在治疗前患者选择偏倚,散发性前庭神经鞘瘤切除的听力保留显微手术显示出良好且稳定的长期可服务听力。
研究设计与样本
- 遵循系统综述与Meta分析首选报告条目指南进行系统文献综述,检索Scopus、Pubmed和Web of Science数据库从建库至2024年1月。
- 纳入标准包括至少5年随访及评估治疗前后听力结局的研究。
- 采用MetaXL软件计算立体定向放射外科和显微手术后可服务听力的合并患病率估计。
- 采用非随机干预研究偏倚风险评估工具进行偏倚风险评估。
- 共9项研究符合纳入标准,356例患者纳入分析。
主要发现
- 立体定向放射外科治疗后10年维持可服务听力的合并患病率为18.1%(95%CI:1.7%-43.3%),预测区间宽提示结局存在变异性。
- 显微手术维持长期可服务听力的患病率更高,合并估计值为74.5%(95%CI:63.5%-84.1%)。
局限性
- 原文指出存在治疗前患者选择固有的偏倚。
- 原文指出立体定向放射外科治疗后10年维持可服务听力的预测区间宽,提示结局存在变异性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hearing loss is a common symptom associated with vestibular schwannoma (VS), either because of the tumor's effects on the cochlear nerve or due to active treatments such as surgery or stereotactic radiosurgery (SRS). Treatment decisions for VS are based on factors including tumor size, hearing status, patient symptoms, and institutional preference. The study aimed to investigate long-term auditory outcomes in VS patients undergoing active treatments with a hearing preservation intent. DATA SOURCES: A systematic literature review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, searching Scopus, Pubmed, and Web of Science databases from inception to January 2024. REVIEW METHODS: Studies meeting inclusion criteria, including a minimum 5-year follow-up and assessment of pre- and posttreatment hearing outcomes, were included. Pooled prevalence estimates for serviceable hearing after SRS and microsurgery were calculated using MetaXL software. Risk of bias assessment was performed with the Risk of Bias in Non-randomized Studies of Interventions tool. RESULTS: Nine studies met the inclusion criteria, with 356 patients included for analysis. The pooled prevalence of maintaining serviceable hearing after SRS at 10 years was 18.1% (95% confidence interval [CI]: 1.7%-43.3%), with wide prediction intervals indicating variability in outcomes. Microsurgery demonstrated a higher prevalence of maintaining long-term serviceable hearing, with a pooled estimate of 74.5% (95% CI: 63.5%-84.1%). CONCLUSION: This systematic review underscores the importance of long-term follow-up in evaluating auditory outcomes in VS treatment. Despite the biases inherent to pretreatment patients selection, hearing preservation microsurgery for sporadic VS removal demonstrated favorable and stable long-term serviceable hearing.
引用
- Daloiso A, Cazzador D, Concheri S, et al. Long-Term Hearing Outcome For Vestibular Schwannomas After Microsurgery And Radiotherapy: A Systematic Review and Meta-Analysis. Otolaryngol Head Neck Surg. 2024. PMID: 39045727. doi:10.1002/ohn.910
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。